Myriad Genetics (LTS:0K3W) General and Admin. Expense : $421.2 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Myriad Genetics General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Myriad Genetics's General and Admin. Expense for the three months ended in Mar. 2024 was $0.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was $421.2 Mil.

Myriad Genetics General and Admin. Expense Historical Data

The historical data trend for Myriad Genetics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myriad Genetics General and Admin. Expense Chart

Myriad Genetics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec21

Dec22

Dec23

General and Admin. Expense

Get a 7-Day Free Trial

556.60

507.30

537.80

514.70

572.90

Myriad Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
General and Admin. Expense	Get a 7-Day Free Trial															151.70	218.20	170.40	32.60	-

Myriad Genetics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $421.2 Mil.

Myriad Genetics General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Myriad Genetics's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Myriad Genetics (LTS:0K3W) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (LTS:0K3W) » Definitions » General and Admin. Expense

Comparable Companies

NEO TWST VCYT NEOG GH SHC OPK LAB CDNA CSTL TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

MYGN:USA MYD:Germany

Address

320 Wakara Way, Salt Lake City, UT, USA, 84108

Website

https://www.myriad.com

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

Myriad Genetics (LTS:0K3W) Headlines

No Headlines